Quotient Limited to Participate in the Morgan Stanley 15th Annual Global Healthcare Conference
August 30 2017 - 8:00AM
Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics
company, today announced that the Company’s Chairman and Chief
Executive Officer, Paul Cowan, will present at the Morgan Stanley
15th Annual Global Healthcare Conference on Wednesday, September
13, 2017 at 1:35 pm Eastern Time at the Grand Hyatt New York in New
York, NY. The Company’s Chief Financial Officer, Chris Lindop, will
also be participating in the conference.
About Quotient Limited
Quotient is a commercial-stage diagnostics company committed to
reducing healthcare costs and improving patient care through the
provision of innovative tests within established markets. With an
initial focus on blood grouping and serological disease screening,
Quotient is developing its proprietary MosaiQ™ technology platform
to offer a breadth of tests that is unmatched by existing
commercially available transfusion diagnostic instrument platforms.
The company's operations are based in Edinburgh, Scotland; Eysins,
Switzerland and Newtown, Pennsylvania.
The Quotient logo and MosaiQ™ are registered trademarks or
trademarks of Quotient Limited and its subsidiaries in various
jurisdictions.
CONTACT:
Christopher Lindop, Chief Financial Officer — christopher.lindop@quotientbd.com; +41 (0)799 61 69 38
Quotient (NASDAQ:QTNT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Quotient (NASDAQ:QTNT)
Historical Stock Chart
From Apr 2023 to Apr 2024